-
Scandic Trust Group strengthens sales network with First Idea Consultant
-
Tight UK security ahead of match against Israeli club
-
Ethiopia's Afar region says attacked by Tigray forces
-
Nancy Pelosi, Democratic giant, Trump foe, first woman House speaker, to retire
-
Israel strikes Hezbollah targets in Lebanon
-
Burger strikes as South Africa restrict Pakistan to 269-9 in second ODI
-
Stocks slip as investors weigh earnings, tariffs
-
Police say 19 held after raid at Swedish start-up Stegra to be deported
-
Kante returns as France seek to clinch World Cup berth
-
Marcus Smith starts at full-back as England ring changes for Fiji
-
Kolisi 100th Test 'no distraction' for Erasmus' South Africa
-
Teetering Belgian government given more time to agree budget
-
Merz backs EU plan to protect steel sector from Chinese imports
-
New Zealand make Scotland changes after Barrett brothers' injuries
-
'Roy of the Rovers story' -- Farrell handed Ireland debut for Japan Test
-
Stones backs Man City team-mate Foden to pose England dilemma for Tuchel
-
Djokovic to face Alcaraz in ATP Finals groups
-
Facing climate 'overshoot', world heads into risky territory
-
Springbok skipper Kolisi to play 100th Test against France
-
Typhoon Kalmaegi hits Vietnam after killing 140 in Philippines
-
Bank of England leaves rate unchanged before UK budget
-
Germany recall Sane, hand El Mala debut for World Cup qualifers
-
India thump Australia to take 2-1 lead in T20 series
-
Cameroon's Biya, world's oldest president, sworn in for 8th term
-
Flick holding firm on Barca high line despite defensive woes
-
Battered US businesses eye improved China trade at Shanghai expo
-
France opt for Le Garrec as Dupont replacement for 'best team ever' South Africa
-
Drugmaker AstraZeneca profit jumps as US business grows
-
'Vibe coding' named word of the year by Collins dictionary
-
Vietnam evacuates thousands from coast ahead of Typhoon Kalmaegi
-
European stocks fall after gains in Asia, US
-
MotoGP legend Agostini admires Marc Marquez's 'desire to win'
-
Nepal searches for avalanche victims
-
Hezbollah rejects any negotiations between Lebanon and Israel
-
Chapman blitz leads Black Caps to tight T20 victory over West Indies
-
France urges EU to sanction Shein platform
-
France opt for Le Garrec as Dupont replacement for South Africa Test
-
Turmoil in tiaras at Miss Universe pageant in Thailand
-
Probe into Thales defence group looking at Indonesian contract
-
US to cancel flights as longest govt shutdown drags on
-
Home in Nigeria, ex-refugees find themselves in a war zone
-
Doncic's Lakers hold off Wembanyama's Spurs, Blazers silence Thunder
-
For Turkey's LGBTQ community, draft law sparks existential alarm
-
Musk's $1 trillion pay package to face Tesla shareholder vote
-
Tonga rugby league star out of intensive care after seizure
-
Argentine ex-president Kirchner goes on trial in new corruption case
-
Dams, housing, pensions: Franco disinformation flourishes online
-
Endo returns as Japan look to build on Brazil win
-
Franco captivates young Spaniards 50 years after death
-
German steel industry girds for uncertain future
RFK Jr ousts entire US vaccine panel over alleged conflicts
US Health Secretary Robert F. Kennedy Jr. on Monday announced he was dismissing all members of a key federal vaccine advisory panel, accusing them of conflicts of interest -- his latest salvo against the nation's immunization policies.
The removal of all 17 experts of the Advisory Committee on Immunization Practices (ACIP) was revealed in a Wall Street Journal op-ed and an official press release.
Kennedy, who has spent two decades promoting vaccine misinformation, cast the move as essential to restoring public trust, claiming the committee had been compromised by financial ties to pharmaceutical companies.
"Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," he said in a statement from the Department of Health and Human Services.
"The public must know that unbiased science -- evaluated through a transparent process and insulated from conflicts of interest — guides the recommendations of our health agencies."
In his op-ed, Kennedy claimed the panel was "plagued with persistent conflicts of interest" and had become "little more than a rubber stamp for any vaccine."
He added that new members were being considered to replace those ousted -- all of whom were appointed under former president Joe Biden.
ACIP members are typically chosen for their recognized expertise and are required to disclose potential conflicts of interest.
The decision was met with alarm by Paul Offit, a pediatrician and leading expert on virology and immunology who served on the panel from 1998 to 2003.
"He believes that anybody who speaks well of vaccines, or recommends vaccines, must be deeply in the pocket of industry," Offit told AFP. "He's fixing a problem that doesn't exist."
Once a celebrated environmental lawyer, Kennedy pivoted from the mid-2000s to public health -- chairing a nonprofit that discouraged routine childhood immunizations and amplified false claims, including the long-debunked theory that the Measles, Mumps and Rubella (MMR) vaccine causes autism.
Since taking office, he has curtailed access to Covid-19 shots and continued to raise fears around the MMR vaccine -- even as the United States faces its worst measles outbreak in years, with three reported deaths and more than 1,100 confirmed cases.
Experts warn the true case count is likely far higher.
"How can this country have confidence that the people RFK Jr. wants on the Advisory Committee for Immunization Practices are people we can trust?" Offit asked.
He recalled that during US President Donald Trump's first term, several states formed independent vaccine advisory panels after the administration pressured federal health agencies to prematurely approve Covid-19 vaccines ahead of the 2020 election.
That kind of fragmentation, Offit warned, could happen again.
ACIP is scheduled to hold its next meeting at the headquarters of the Centers for Disease Control and Prevention in Atlanta from June 25 to June 27.
Vaccines for anthrax, Covid-19, human papillomavirus, influenza, Lyme disease, respiratory syncytial virus, and more are on the agenda.
Ch.Kahalev--AMWN